间歇性跛行文献缺乏以患者为中心的结果评估
该系统综述检索2000年1月1日至2022年11月30日多个数据库,纳入26项评估运动疗法、血管内或开放血运重建治疗间歇性跛行的研究,发现主要肢体不良事件、生活质量和步行距离等患者相关结局数据稀疏,尤其缺乏运动疗法与侵入性干预的比较效果证据。
要点
- 间歇性跛行文献中患者报告结局指标和标准化步行距离测量存在重大证据缺口。
- 血管内治疗≥2年再干预率>20%,1个月死亡率<2%,但主要截肢率常未报告。
- 生活质量和步行距离数据仅限血管内干预且不足以得出强结论。
核心结论
- 间歇性跛行文献在患者报告结局指标、标准化步行距离测量以及初始运动疗法与侵入性干预的比较效果方面存在重大证据缺口。
- 血管外科学会间歇性跛行适当使用标准系统综述识别的证据缺口可作为未来研究优化该人群治疗的指南。
研究设计与样本
- 系统综述,检索MEDLINE、EMBASE、Cochrane Central Register of Controlled Trials、Cochrane Database of Systematic Reviews和Scopus,时间范围为2000年1月1日至2022年11月30日。
- 纳入非比较性和比较性观察研究及随机对照试验,评估运动疗法、血管内或开放血运重建治疗间歇性跛行。
- 26项研究报告了证据图谱的兴趣结局。
主要发现
- 报告免于主要肢体不良事件的研究一般结论为:血管内治疗≥2年再干预率>20%,主要截肢率常未报告,血管内治疗后1个月死亡率低(<2%)。
- 生活质量和步行距离数据稀疏,仅限于血管内干预,不足以得出任何强结论。
临床怎么用
- 原文未据此给出推荐。
局限性
- 生活质量和步行距离数据稀疏,仅限于血管内干预,不足以得出任何强结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Peripheral arterial disease, characterized as arterial atherosclerotic disease, can lead to insufficient flow in the lower extremities and ischemia, with the most common clinical manifestation being intermittent claudication (IC). In 2022, the Society for Vascular Surgery (SVS) developed appropriate use criteria for the management of IC that used this systematic review as a source of evidence. The objective of this study is to synthesize the findings of the systematic review and identify evidence gaps. METHODS: A comprehensive search of literature databases including MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus was conducted from January 1, 2000, to November 30, 2022. Noncomparative and comparative observational studies and randomized controlled trials were included. Included studies evaluated exercise therapy, endovascular or open revascularization for the treatment of IC. Outcomes of interest (freedom from major adverse limb event, health-related quality of life, and walking distance) were compared in various subgroups (age, sex, diabetes, smoking status, anatomical location of disease, and optimal medical therapy). RESULTS: Twenty-six studies reported the outcomes of interest for the evidence map. The general conclusions of the studies that reported freedom from major adverse limb events were that reintervention rates for endovascular therapy at ≥2 years were >20%, major amputation rates were often not reported, and, after endovascular therapy, the 1-month mortality was low (<2%). Quality of life and walking distance data were sparse, limited to only endovascular intervention, and insufficient to make any strong conclusions. CONCLUSIONS: IC in patients with peripheral arterial disease poses a significant socioeconomic and health care burden. Major, consequential gaps exist in the IC literature with respect to the assessment of patient reported outcome measures, standardized measures of walking distance and the comparative effectiveness of initial exercise therapy vs invasive intervention. The evidence gaps identified by the Society for Vascular Surgery appropriate use criteria on IC systematic review serve as a guide for future research efforts to optimize care for this patient population.
引用
- O'Banion LA, Saadi S, Hasan B, et al. Lack of patient-centered evaluation of outcomes in intermittent claudication literature. J Vasc Surg. 2023. PMID: 37044317. doi:10.1016/j.jvs.2023.03.497
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。